Spots Global Cancer Trial Database for immunosuppressive agents

Every month we try and update this database with for immunosuppressive agents cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Natural Killer Cell (CYNK-001) Infusions in Adults With AML	NCT04310592	Leukemia Leukemia, Myelo... Leukemia, Myelo... Neoplasms by Hi... Neoplasms Immunosuppressi... Immunologic Fac... Physiological E... Alkylating Agen... Antimetabolites... Antiviral Agent... Analgesics, Non... Anti-infective ... Analgesics Peripheral Nerv... Hematologic Dis... Hematologic Neo... Leukemia in Rem... Relapsed Adult ... Refractory AML	CYNK-001	18 Years - 80 Years	Celularity Incorporated
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas	NCT04305444	Relapsed Chroni... Refractory Chro... Diffuse Large B... Follicular Lymp... Richter's Trans...	DTRM-555	18 Years -	Zhejiang DTRM Biopharma
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type	NCT05218408	Astrocytoma, Gr... Glioblastoma Giant Cell Glio... Glioblastoma Mu...	CYNK-001 system...	18 Years -	Celularity Incorporated
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis	NCT06001385	Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis	Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid...	18 Years -	Center for International Blood and Marrow Transplant Research
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT	NCT02627573	Leukemia, Chron... Myelodysplastic... Leukemia, Myelo...	Unrelated allog... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Cyclophosphamid... Thymoglobulin	18 Years - 75 Years	St. Petersburg State Pavlov Medical University
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	NCT02294552	Acute Myeloid L... Acute Lymphoid ... Lymphoma Myelodysplastic... Chronic Lymphoc... Immune System D...	Cyclophosphamid... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Allogeneic hema...	18 Years - 65 Years	St. Petersburg State Pavlov Medical University
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia	NCT02799147	Leukemia, Acute... Acute Myeloid L... Mixed-Lineage A...	Allogeneic stem... Fludarabine mon... Busulfan Bendamustine	18 Years - 60 Years	St. Petersburg State Pavlov Medical University
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM	NCT04489420	Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... Cyclophosphamid... Immunosuppressi... Immunologic Fac... Physiological E... Molecular Mecha... Antiviral Agent... Anti-infective ... Analgesics, Non... Analgesics Sensory System ... Peripheral Nerv...	CYNK001-IV CYNK001-IT	18 Years -	Celularity Incorporated
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer	NCT00838578	Colorectal Canc...	KRN330 Irinotecan	18 Years -	Kyowa Kirin Co., Ltd.
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients	NCT02944045	Pneumocystis Steroids Immunocompromis... Hematologic Neo... Immunosuppressi... Neoplasms	Methylprednisol... Placebo	18 Years -	Assistance Publique - Hôpitaux de Paris
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma	NCT00365274	Anaplastic Larg...	Cyclophosphamid... Doxorubicin hyd... vincristine sul... prednisone SGN-30	18 Years -	National Cancer Institute (NCI)
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas	NCT04305444	Relapsed Chroni... Refractory Chro... Diffuse Large B... Follicular Lymp... Richter's Trans...	DTRM-555	18 Years -	Zhejiang DTRM Biopharma
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide	NCT04904588	Acute Lymphobla... Acute Myelogeno... Mixed Phenotype... Acute Leukemia Myelodysplastic... Chronic Myeloge... Chronic Lymphoc... Lymphoma	Busulfan Busulfan Fludarabine Total-body irra... Cyclophosphamid... Melphalan PBSC Hematopoie... Bone Marrow Hem... Post-transplant... Mesna Tacrolimus Mycophenolate M... Patient-Reporte...	1 Year -	Center for International Blood and Marrow Transplant Research
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type	NCT05218408	Astrocytoma, Gr... Glioblastoma Giant Cell Glio... Glioblastoma Mu...	CYNK-001 system...	18 Years -	Celularity Incorporated
Natural Killer Cell (CYNK-001) Infusions in Adults With AML	NCT04310592	Leukemia Leukemia, Myelo... Leukemia, Myelo... Neoplasms by Hi... Neoplasms Immunosuppressi... Immunologic Fac... Physiological E... Alkylating Agen... Antimetabolites... Antiviral Agent... Analgesics, Non... Anti-infective ... Analgesics Peripheral Nerv... Hematologic Dis... Hematologic Neo... Leukemia in Rem... Relapsed Adult ... Refractory AML	CYNK-001	18 Years - 80 Years	Celularity Incorporated
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis	NCT01743560	Oestrogen Recep...	RAD001 Exemestane	18 Years -	Novartis

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: